T 2410/19 (PCV2 composition/BOEHRINGER INGELHEIM) of 16.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T241019.20230316
- Date of decision
- 16 March 2023
- Case number
- T 2410/19
- Petition for review of
- -
- Application number
- 06850366.3
- IPC class
- A61K 39/12
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PCV2 immunogenic composition for lessening clinical symptoms in pigs
- Applicant name
- Boehringer Ingelheim Animal Health USA Inc.
- Opponent name
- Eli Lilly and Company
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(5)European Patent Convention Art 56
- Keywords
- Admissibility of opposition - (yes)
Inventive step - (no) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.